These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 11145184)

  • 21. Glioblastoma treatment: bypassing the toxicity of platinum compounds by using liposomal formulation and increasing treatment efficiency with concomitant radiotherapy.
    Charest G; Sanche L; Fortin D; Mathieu D; Paquette B
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):244-9. PubMed ID: 22284691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery of platinum (II) drugs with bulky ligands in trans-geometry for overcoming cisplatin drug resistance.
    Yang X; Yu Y; Huang X; Chen Q; Wu H; Wang R; Qi R; Miao Y; Qiu Y
    Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():96-104. PubMed ID: 30606608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased delivery of a new cisplatin analogue (254-S) in a rat brain tumor by an intracarotid infusion of bradykinin.
    Koga H; Inamura T; Ikezaki K; Nomura T; Samoto K; Fukui M
    Neurol Res; 1996 Jun; 18(3):244-7. PubMed ID: 8837061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liposomes as carriers of cisplatin into the central nervous system--experiments with 9L gliomas in rats.
    Shibata S; Ochi A; Mori K
    Neurol Med Chir (Tokyo); 1990 Apr; 30(4):242-5. PubMed ID: 1696693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma].
    Miyagami M; Tazoe M; Kasahara E; Tsubokawa T
    Gan To Kagaku Ryoho; 1989 May; 16(5):2059-65. PubMed ID: 2499268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF; Macias RI; Izco-Basurko I; de La Fuente A; Pascual MJ; Criado JM; Monte MJ; Yajeya J; Marin JJ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1106-12. PubMed ID: 11356935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of the action of antineoplastic platinum compounds with varying nephrotoxic effects].
    Bakhteeva VT; Fok EM; Lavrova EA
    Vopr Med Khim; 1996; 42(4):301-6. PubMed ID: 9254514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics of tissue disposition of cis-ammine/cyclohexylamine-dichloroplatinum(II) and cisplatin in mice bearing FSaIIC tumors.
    Yoshida M; Khokhar AR; Zhang YP; Thai G; Siddik ZH
    Cancer Chemother Pharmacol; 1994; 35(1):38-44. PubMed ID: 7987975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of aqua (1,1-bis(aminomethyl)cyclohexane) sulfatoplatinum (II) (spiroplatin) during a phase I trial.
    van der Vijgh WJ; Elferink F; Vermorken JB; ten Bokkel Huinink WW; Klein I; Gall HE; Simonetti G; McVie JG; Pinedo HM
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):621-7. PubMed ID: 3383966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platinum concentrations in uterus and serum after internal iliac arterial infusion of platinum compounds in rabbits.
    Kigawa J; Minagawa Y; Itamochi H; Kanamori Y; Ishihara H; Terakawa N
    Obstet Gynecol; 1995 Aug; 86(2):265-8. PubMed ID: 7617358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacodynamics of tongue tissue and plasma after intraarterial infusion of cis-diammine glycolato platinum (CDGP)].
    Matsui T; Kano M
    Nihon Jibiinkoka Gakkai Kaiho; 2004 Nov; 107(11):990-7. PubMed ID: 15624504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Difference in CDDP penetration into CSF between selective intraarterial chemotherapy in patients with malignant glioma and intravenous or intracarotid administration in patients with metastatic brain tumor.
    Nakagawa H; Fujita T; Kubo S; Tokiyoshi K; Yamada M; Kanayama T; Hagiwara Y; Nakanomyo H; Hiraoka M
    Cancer Chemother Pharmacol; 1996; 37(4):317-26. PubMed ID: 8548876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced systemic drug exposure by combining intraarterial cis-diamminedichloroplatinum(II) with hemodialysis of regional venous drainage.
    Oldfield EH; Clark WC; Dedrick RL; Egorin MJ; Austin HA; DeVroom HD; Joyce KM; Doppman JL
    Cancer Res; 1987 Apr; 47(7):1962-7. PubMed ID: 3815385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo microdialysis to characterize drug transport in brain tumors: analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats.
    Devineni D; Klein-Szanto A; Gallo JM
    Cancer Chemother Pharmacol; 1996; 38(6):499-507. PubMed ID: 8823490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model.
    Dzodic R; Gomez-Abuin G; Rougier P; Bonnay M; Ardouin P; Gouyette A; Rixe O; Ducreux M; Munck JN
    Anticancer Drugs; 2004 Jul; 15(6):647-50. PubMed ID: 15205611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats.
    Hanada K; Asano K; Nishimura T; Chimata T; Matsuo Y; Tsuchiya M; Ogata H
    J Pharm Pharmacol; 2008 Mar; 60(3):317-22. PubMed ID: 18284811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical pharmacokinetics and excretion of new platinum analogues in rodents.
    Webster LK; Ellis AG; Apicella C; Deacon GB
    Cancer Chemother Pharmacol; 2002 Jan; 49(1):87-92. PubMed ID: 11855757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Distribution of cis-diamminedichloroplatinum in patients with metastatic brain tumors after intravenous or intracarotid administration].
    Nakagawa H; Fujita T; Izumoto S; Kubo S; Nakajima Y; Turuzono K
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):103-9. PubMed ID: 1987891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetics of carboplatin.
    van der Vijgh WJ
    Clin Pharmacokinet; 1991 Oct; 21(4):242-61. PubMed ID: 1760899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.